Prescribing patterns in patients with chronic obstructive pulmonary disease and atrial fibrillation

Prescribing patterns in patients with chronic obstructive pulmonary disease and atrial fibrillation

Patients with chronic obstructive pulmonary disease (COPD) had higher risk of atrial fibrillation (AF). The treatment of AF includes medicines to control heart rate and reduce the risk of stroke, and procedures such as cardioversion to restore normal heart rhythm. To reduce the stroke, patients with...

Full description

Bibliographic Details
Main Authors:	Liao Kuang-Ming, Chen Pei-Jun, Chen Chung-Yu
Format:	Article
Language:	English
Published:	De Gruyter 2023-11-01
Series:	Open Medicine
Subjects:	atrial fibrillation chronic obstructive pulmonary disease non- vitamin k antagonist oral anticoagulants prescribing pattern proportion of days covered
Online Access:	https://doi.org/10.1515/med-2023-0864

Similar Items

Pattern of oral anticoagulant prescribing for atrial fibrillation in general practice: an observational study in The Netherlands
by: Catharina CM Kager, et al.
Published: (2023-03-01)

2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
by: Chern-En Chiang, MD, PhD, et al.
Published: (2017-08-01)

Effect of edoxaban compared with other oral anticoagulants for stroke prevention in patients with atrial fibrillation: A meta-analysis
by: Bailin Zhang, et al.
Published: (2023-11-01)

Prevention of thromboembolic complications in patients with atrial fibrillation and obesity
by: Izabela Kolasa, et al.
Published: (2023-04-01)

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
by: Gilda Denise Zielinski, et al.
Published: (2020-01-01)

PRACTICAL CONCERNS OF ANTICOAGULATION IN NONVALVULAR ATRIAL FIBRILLATION: A UNIVERSITY CLINICS REGISTRY
by: A. A. Sokolova, et al.
Published: (2015-09-01)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
by: Suárez Fernández C, et al.
Published: (2018-02-01)

Impact of baseline renal function on the efficacy and safety of different Anticoagulants in Atrial Fibrillation Patients – A cohort study
by: Wei-Chieh Lee, et al.
Published: (2022-10-01)

Challenges of anticoagulant treatment in atrial fibrillation with liver disease
by: Alina Doina Nicoara, et al.
Published: (2024-10-01)

Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation – real-life data from a survey in Eastern Switzerland
by: Micha T. Maeder, et al.
Published: (2017-10-01)

Novel oral anticoagulants in primary care in patients with atrial fibrillation: a cross-sectional comparison before and after their introduction
by: Simon Schwill, et al.
Published: (2018-07-01)

Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry
by: Luca Masotti, et al.
Published: (2014-06-01)

Efficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-Analysis
by: Guan-lian Mo, et al.
Published: (2025-01-01)

Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials
by: Kang-Ling Wang, et al.
Published: (2017-08-01)

Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
by: Wenhao Li, et al.
Published: (2022-09-01)

Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA‐AF Phase III Registry
by: Valentina Bayer, et al.
Published: (2022-03-01)

Post-TAVR patients with atrial fibrillation: are NOACs better than VKAs?—A meta-analysis
by: Lu Wang, et al.
Published: (2023-08-01)

Design, Rationale and Initial Findings From HERA‐FIB on 10 222 Patients With Atrial Fibrillation Presenting to an Emergency Department Over An 11‐Year Period
by: Christian Salbach, et al.
Published: (2024-05-01)

Safety and efficacy of direct oral anticoagulants compared to Vitamin K antagonists postpercutaneous coronary interventions in patients with atrial fibrillation: A systematic review and meta‐analysis
by: Pradyumna Agasthi, et al.
Published: (2020-04-01)

The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation
by: Si-qi Lyu, et al.
Published: (2024-01-01)

Comparative safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation: A network meta-analysis
by: Yi-Hsin Chan, et al.
Published: (2024-05-01)

Real-practice thromboprophylaxis in atrial fibrillation
by: Deambrosis Paola, et al.
Published: (2017-06-01)

A cross-sectional study of appropriateness evaluation of anticoagulation therapy for inpatients with nonvalvular atrial fibrillation
by: Xiao-Yuan Zheng, et al.
Published: (2023-12-01)

Do Apixaban Plasma Levels Relate to Bleeding? The Clinical Outcomes and Predictive Factors for Bleeding in Patients with Non-Valvular Atrial Fibrillation
by: Sutee Limcharoen, et al.
Published: (2022-08-01)

Non-Vitamin K Oral Anticoagulants Assessment in High Risk of Bleeding Patients with Non-Valvular Atrial Fibrillation
by: Pedro Silva Cunha, et al.
Published: (2022-02-01)

Efficacy and safety of anticoagulation in atrial fibrillation patients with intracranial hemorrhage: A systematic review and meta-analysis
by: Qiang Zhou, et al.
Published: (2023-03-01)

Anticoagulation therapy in the elderly with non-valvular atrial fibrillation: a double-edged sword
by: Francesco Vetta, et al.
Published: (2017-07-01)

Oral anticoagulation – current knowlegde
by: Anna Karaś, et al.
Published: (2022-10-01)

Development and Validation of an Intracranial Hemorrhage Risk Score in Older Adults with Atrial Fibrillation Treated with Oral Anticoagulant
by: Bessette LG, et al.
Published: (2024-04-01)

ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. I. Leonova, et al.
Published: (2015-09-01)

Efficacy and Safety of Renal Function on Edoxaban Versus Warfarin for Atrial Fibrillation: A Systematic Review and Meta-Analysis
by: Yapeng Wang, et al.
Published: (2023-01-01)

Effects of direct oral anticoagulants vs. vitamin K antagonists on acute kidney injury in patients with atrial fibrillation: A systematic review
by: Chengfa Ren, et al.
Published: (2023-01-01)

Stroke prevention for non-valvular atrial fibrillation: how to make the right choice of directly acting oral anticoagulants?
by: N. N. Kryukov, et al.
Published: (2019-02-01)

Low Dose of Direct Oral Anticoagulants after Left Atrial Appendage Occlusion
by: Pedro Luis Cepas-Guillen, et al.
Published: (2021-10-01)

Effect of current smoking on ischemic events in patients with atrial fibrillation taking vitamin K antagonist
by: Hideki Arai, et al.
Published: (2022-09-01)

The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis
by: Sohil Elfar, et al.
Published: (2024-01-01)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
by: Alfredo Caturano, et al.
Published: (2019-09-01)

The use of oral anticoagulants in patients with atrial fibrillation: cohort study data
by: O. V. Gaisenok, et al.
Published: (2016-09-01)

A novel shared decision-making (SDM) tool for anticoagulation management in atrial fibrillation: protocol for a prospective, cluster randomized controlled trial
by: Mang-Mang Pan, et al.
Published: (2023-10-01)

Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS‐SPAF)
by: Moonki Jung, et al.
Published: (2023-06-01)